HUTCHMED (China) Limited ( HCM) - Key Metrics
HCM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.80 | $0.05 | $0 | $0 |
| 2026Q1 | $0.80 | $0.05 | $0.04 | $0.02 |
| 2025Q4 | $0.07 | $0 | $0 | $0 |
| 2025Q3 | $0.07 | $0 | $0 | $0 |
| 2025Q2 | $0.79 | $1.30 | -$0.21 | -$0.23 |
HCM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 58.48 |
| 2026Q1 | 0% | 81.30 |
| 2025Q4 | 0% | 605.91 |
| 2025Q3 | 0% | 715.91 |
| 2025Q2 | 0% | 2.79 |
HCM
Price: $14.20
52 week price:
Earnings Per Share: 0.10 USD
P/E Ratio: 115.70
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Hong Kong
Volume: 680726
Market Capitalization: 2.5 billion